The paradoxical effects of somatostatin on the bioactivity and production of cytotoxins derived from human peripheral blood mononuclear cells

British Journal of Cancer

Volumn 64, Issue 2, 1991, Pages 243-246

  Yousefi, S ^a   Vaziri, N ^a   Carandang, G ^a   Le, W ^a   Yamamoto, R ^a   Granger, G ^a   Ocariz, J ^a   Cesario, T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN; LYMPHOTOXIN; SOMATOSTATIN;

ARTICLE; CELL STRAIN L 929; CYTOTOXICITY; DRUG ACTIVITY; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

CYTOTOXICITY, IMMUNOLOGIC; HUMAN; LYMPHOTOXIN; MONOCYTES; RECOMBINANT PROTEINS; SOMATOSTATIN; TUMOR NECROSIS FACTOR;

EID: 0025769899     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1991.284     Document Type: Article

References (27)

1. BERENBAUM, M., FLUCK, P. & HURST, N. (1975). Depression of lymphocyte responses after surgical trauma. Br. J. Exp. Path., 54, 597
2. BOYUM, A. (1968). Isolation of mononuclear cells and granulocytes from human blood. Scand. Journ. Clin. Invest., 97, (Suppl.) 77
3. BRAZEAU, P., VALE, W. & BURGUS, R. (1973). Hypothalamic peptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science, 179, 77
4. BROWNING, J. & RIBOLINI, A. (1989). Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines. J. Immunol., 143, 1859
5. CERTURI, M., MURPHY, M., COSTA-GROMI, M., WEINMANN, R., PERUSSIA, B. & TRINCHIERI, G. (1987). Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J. Exp. Med., 165, 1581
6. CESARIO, T., MCCLOSKEY, M., CARANDANG, G., YOUSEFI, S., CHIU, J. & VAZIRI, N. (1988). Calcium and the production of interferon by human peripheral blood mononuclear cells. J. Interferon Res., 8, 783
7. GOEDDEL, D., AGGARWAL, B., GRAY, P. & 6 others (1986). Tumor necrosis factor: gene structure and biological activities. Cold Spring Harbor Symposium in Quant. Biol., 51, 597
8. GOETZL, E., CHERNOV-ROGAN, T., COOKE, M., RENOLD, F. & PAYAN, D. (1985). Endogenous somatostatin-like peptides of rat basophilic leukemia cells. J. Immunol., 135, 2707
9. GORDON, P., COMI, R., MATON, P. & GO, V. (1989). Somatostatin and somatostatin analogues (SMS201-955) in the treatment of hormone secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Ann. Internal Med., 110, 35
10. GUSTAVSSON, S. & LUNDQUIST, G. (1978). Inhibition of pancreatic somatostatin release in response to glucose. Biochem. Biophys. Res. Commun., 82, 1229
11. KUTZ, K., NUESCH, E. & ROZENTHALER, J. (1986). Pharmacokinetics of SMS 201-995 in healthy subjects. Scand. J. Gastroenterol., 119, (Suppl. 21) 65.
12. LABHART, A. (1986). Tissue Hormones. In Clinical Endocrinology. (Second Edition) Labhart, A. (ed.). Springer-Verlag: New York
13. LEWIS, J., CARMACK, C., YAMAMOTO, R. & GRANGER, G. (1977). Antibodies against human lymphokines. I. Methods for induction of antibodies capable of neutralizing stable alpha and unstable beta lymphotoxins released in vitro by activated lymphocytes. J. Immuno. Methods, 14, 163
14. MASCARDO, R., BARTON, R. & SHARLINE, P. (1984). Somatostatin has an antiproliferative effect on concanavalin A activated rat thymocytes. Clin. Immunol. & Immunopath., 33, 131
15. MCCANN, S., KURLICH, L., NEGRO-VILAR, A., OJEDA, S. & VIJAYAN, E. (1980). Regulation and function of panhibin (Somatostatin). Adv. Biochem. Psychopharmacol., 2, 131
16. PACE, C.S. & TARVIN, J.T. (1981). Somatostatin: mechanism of action on pancreatic islet cells. Diabetes, 30, 836
17. PAUL, N. & RUDDLE, N. (1988). Lymphotoxin. Ann. Rev. Immunol., 6, 407
18. PAWLIKOWSKI, M., STEPIEN, H., KUNERT-RADEK, J. & SHALLY, A. (1985). Effect of somatostatin on the proliferation of mouse spleen cells in vitro. Biochem. Biophys. Res. Commun., 129, 52
19. PAYAN, D., HESS, C. & GOETZL, E. (1984). Inhibition by somatostatin of the proliferation of T lymphocytes and Molt 4 lymphoblasts. Cellular Immunol., 84, 433
20. REICHLIN, S. (1983). Somatostatin. N. Eng. J. Med., 309, 1495
21. SCHALLY, A. (1988). Oncological applications of somatostatin analogs. Cancer Res., 48, 6977
22. SCHALLY, A., HUANG, W., CHANG, P. & 5 others (1980). Isolation and structure of pre somatostatin: a putative somatostatin precursor from pig hypothalamus. Proc. Natl Acad. Sci. USA, 77, 4489
23. STANISZ, A., BEFUS, D. & BIENENSTOCK, J. (1986). Differential effects of vasoactive intestinal peptide, substance P and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer’s patches, mesenteric lymph nodes and spleen. J. Immunol., 135, 152
24. WAGNER, M., MENGST, K., ZIERDEN, E. & GERLACH, U. (1979). Investigations of the antiproliferative effect of somatostatin in man and rats. Metab. Clin. Exp., 27, 1381
25. WUNSCH, E., JAEGER, F., MORODER, L., PEGGIM, E. & PALUMBO, M. (1981). Somatostatin-28: a conformational analysis. Biopolymers, 20, 1741
26. YAMAMOTO, R., WARE, C. & GRANGER, G. (1986). The human LT system. XI Identification of LT and TNF like LT forms from stimulated natural killers, specific and nonspecific cytotoxic human T cells in vitro. J. Immunol., 137, 1978
27. YOUSEFI, S., GHAZINOURI, A., VAZIRI, N., TILLES, J., CARDANDANG, G. & CESARIO, T. (1990). The effect of somatostatin on the production of human interferons by mononuclear cells. Proc. Soc. Exp. Biol. Med., 194, 114